Skip to main content
Livermore
Livermore
ZHEN

Tarsus Pharmaceuticals, Inc.

TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001819790

In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Tarsus Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of TARS: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders1953195+3
Shares40.3M142.3K44.0M+3.84M (+9.6%)
Value$2.23B$7.88M$2.26B+$37.1M (+1.7%)

3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (37)

Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to TARS in Q1 2025
InstitutionSharesValue% of portfolio
Deep Track Capital, LP1,484,266$76.2M2.47%
Driehaus Capital Management LLC717,853$36.9M0.36%
OrbiMed Advisors LLC653,743$33.6M0.81%
Adage Capital Partners GP, L.L.C.510,000$26.2M0.05%
Norges Bank391,061$20.1M0.00%
Nuveen, LLC264,523$13.6M0.00%
Castleark Management LLC74,920$3.85M0.13%
Commonwealth Equity Services, LLC71,592$3.68M0.01%
Balyasny Asset Management LLC59,674$3.07M0.01%
Jump Financial, LLC48,800$2.51M0.04%
Ghisallo Capital Management LLC40,000$2.05M0.18%
Universal- Beteiligungs- und Servicegesellschaft mbH35,393$1.82M0.00%
Twinbeech Capital LP28,173$1.45M0.03%
SummitTX Capital, L.P.16,388$841.9K0.04%
Quantbot Technologies LP16,020$822.9K0.03%
Warren Averett Asset Management, LLC16,009$822.4K0.01%
OmniStar Financial Group, Inc.8,367$429.8K0.34%
CIBC World Markets Corp8,260$424.3K0.00%
Springhill Fund Asset Management (HK) Co Ltd7,076$363.5K1.74%
Virtus Investment Advisers, Inc.7,025$360.9K0.10%
Engineers Gate Manager LP6,727$345.6K0.01%
Graham Capital Management, L.P.6,500$333.9K0.01%
Valmark Advisers, Inc.5,500$282.5K0.00%
FORA Capital, LLC5,284$271.4K0.03%
Occudo Quantitative Strategies LP5,228$270.5K0.04%
Sandia Investment Management LP5,000$256.9K0.75%
Quest Partners LLC3,672$188.6K0.02%
BI Asset Management Fondsmaeglerselskab A/S579$30.0K0.00%
Group One Trading, L.P.571$29.3K0.00%
Massmutual Trust Co FSB210$10.8K0.00%
Optiver Holding B.V.184$9.45K0.00%
US Bancorp28$1.44K0.00%
Geneos Wealth Management Inc.0$1.23K0.00%
Signaturefd, LLC15$7710.00%
Coldstream Capital Management Inc12$6160.00%
Parkside Financial Bank & Trust10$5150.00%
Stephens Consulting, LLC10$5140.00%

Sold out (34)

Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of TARS in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
AIGH Capital Management LLC224,713$12.4M
Perceptive Advisors LLC186,662$10.3M
Principia Wealth Advisory, LLC138,445$7.67M
Advisory Services Network, LLC60,459$3.35M
Diadema Partners LP60,000$3.32M
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.59,204$3.28M
Two Sigma Advisers, LP53,500$2.96M
Exome Asset Management LLC28,178$1.56M
Artia Global Partners LP20,811$1.15M
Y-Intercept (Hong Kong) Ltd15,118$837.1K
Persistent Asset Partners Ltd15,477$832.0K
Tudor Investment Corp Et Al13,880$768.5K
XTX Topco Ltd11,375$629.8K
Prelude Capital Management, LLC8,778$486.0K
Freestone Grove Partners LP7,921$438.6K
Alpha DNA Investment Management LLC7,818$432.9K
Omers Administration Corp7,400$409.7K
Virtus ETF Advisers LLC6,845$379.0K
Sherbrooke Park Advisers LLC6,571$363.8K
Capula Management Ltd6,396$354.1K
Bleakley Financial Group, LLC5,825$322.5K
Voleon Capital Management LP5,266$291.6K
Corton Capital Inc.4,714$261.0K
Baader Bank INC4,500$249.2K
Centiva Capital, LP3,959$219.2K
Sargent Investment Group, LLC4,465$209.9K
HighTower Advisors, LLC3,734$206.8K
R Squared Ltd960$53.2K
Venturi Wealth Management, LLC861$47.7K
Coppell Advisory Solutions LLC394$21.6K
Aster Capital Management (DIFC) Ltd218$12.1K
Clear Street Markets LLC157$8.69K
Smartleaf Asset Management LLC27$1.48K
WPG Advisers, LLC9$498

Not filed for Q1 2025 yet (3)

Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TARS in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC125,539$6.95M
Caxton Associates LP16,588$918.5K
Hanseatic Management Services Inc139$7.70K